Proof-of-mechanism has been established for TNG260 based on pharmacodynamic data from on-treatment patient biopsies, with ...

To get Belinda home, the Doctor takes the Vindicator to Lagos, Nigeria, to piggyback on the country’s communications network.

SG&A Expenses: Selling, general and administrative expenses were $29.3 million for the first quarter of 2025 compared to ...

Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 - - Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 - - Cash position ...

Third, the severe clinical outcomes and EMA orphan disease designation support ... At the upcoming EASL Congress, we'll be presenting a poster showcasing data from a 24-week subgroup analysis ...

And it’s evolving in a way that highly, that really benefits our focus in these patients ... led to the award of rare pediatric disease and orphan drug status for the treatment of epidermolysis ...

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the presentation of new preclinical data for its lead drug ...

OJEMDA (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cas ...

Ten (10) patients have achieved an objective response (5 confirmed) when treated with MDNA11 alone or in combination with KEYTRUDA® (pembrolizumab) – all responders had advanced and/or metastatic ...

It’s all done via Steve Albini’s Closet where you can by books, LPs, CDs, posters, t-shirts, flyers, zines, posters/flyers, “mysterious bargains,” and more from his collection. Here’s ...

Sebastian Stan is owning his membership of The New Avengers. Earlier this morning, Marvel Studios tweeted a video of the actor, who has long portrayed James “Bucky” Buchanan Barnes in the ...